 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Diagnosing Gout between Painful Episodes
16 November 1999 | Volume 131 Issue 10 | Page 756
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Synovial Fluid Analysis for Diagnosis of Intercritical Gout." It is in the 16 November 1999 issue of Annals of Internal Medicine (volume 131, pages 756-759). The authors are E. Pascual, E. Batlle-Gualda, A. Martínez, J. Rosas, and P. Vela.
What is the problem and what is known about it so far?
Gout is a type of arthritis that happens when uric acid crystals form in a joint. These crystals can form when blood levels of uric acid are high. The underlying cause of gout is unknown, but it tends to run in families. Any joint may be involved, but the joint where the big toe meets the foot is the most common site. During gout attacks, which tend to occur periodically, the joints become swollen, red, and painful. To diagnose gout, a physician puts a needle into the affected joint and removes some joint fluid (synovial fluid), then uses a microscope to look for uric acid crystals in this fluid. The diagnosis is more difficult if a person is not in the middle of a gout attack.
Why did the researchers do this particular study?
The researchers wanted to find out whether examination of the joint fluid could help to diagnose gout even when someone is not currently having an attack.
Who was studied?
The researchers studied 101 patients who had previously been diagnosed with gout, but whose last gout attack had stopped at least 2 months before the study.
How was the study done?
The researchers collected information on the study patients' history of gout, blood levels of uric acid, and anti-gout medications. They then inserted a small needle into each patient's big toe or knee joints to obtain samples of joint fluid. The joints studied had been involved in previous gout attacks. The researchers next examined this fluid under a microscope to look for gout crystals.
What did the researchers find?
The researchers could get fluid from 91 of the 101 joints (73 of 80 knees and 18 of 21 toes). The fluid contained crystals in all 43 patients who were not receiving anti-gout medicines but in only 34 of the 48 patients who were taking anti-gout medicines. The patients without crystals in the joint fluid had not had a gout attack for a longer period of time, had lower blood levels of uric acid, and were receiving anti-gout medicine for a longer time than patients who had crystals.
What were the limitations of the study?
The study is relatively small, so it had limited ability to identify specific factors that would be related to the absence of crystals in the joint.
What are the implications of the study?
Analysis of the joint fluid may be helpful in diagnosing gout during periods in which a patient has no swollen, painful joints.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  E Pascual and M Doherty Aspiration of normal or asymptomatic pathological joints for diagnosis and research: indications, technique and success rate Ann Rheum Dis, January 1, 2009; 68(1): 3 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M K Reinders, E N van Roon, T L T. A Jansen, J Delsing, E N Griep, M Hoekstra, M A F J van de Laar, and J R B J Brouwers Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol Ann Rheum Dis, January 1, 2009; 68(1): 51 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Chang, C.-J. Chen, F.-C. Tsai, H.-M. Lai, P.-C. Tsai, M.-H. Tsai, and Y.-C. Ko Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor {beta}1 gene Rheumatology, May 1, 2008; 47(5): 617 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Sivera, R Aragon, and E Pascual First metatarsophalangeal joint aspiration using a 29-gauge needle Ann Rheum Dis, February 1, 2008; 67(2): 273 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Pascual and F. Sivera Why is gout so poorly managed? Ann Rheum Dis, October 1, 2007; 66(10): 1269 - 1270. [Full Text] [PDF]
|
|
|
|
|
|
E. Roddy, W. Zhang, and M. Doherty Are joints affected by gout also affected by osteoarthritis? Ann Rheum Dis, October 1, 2007; 66(10): 1374 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Roddy, W. Zhang, and M. Doherty Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations Ann Rheum Dis, October 1, 2007; 66(10): 1311 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Pascual and F. Sivera Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout Ann Rheum Dis, August 1, 2007; 66(8): 1056 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W Zhang, M Doherty, E Pascual, T Bardin, V Barskova, P Conaghan, J Gerster, J Jacobs, B Leeb, F Liote, et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT) Ann Rheum Dis, October 1, 2006; 65(10): 1301 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Martinez Sanchis and E Pascual Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy Ann Rheum Dis, December 1, 2005; 64(12): 1769 - 1772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Suresh Diagnosis and management of gout: a rational approach Postgrad. Med. J., September 1, 2005; 81(959): 572 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Dalbeth and D. O. Haskard Mechanisms of inflammation in gout Rheumatology, September 1, 2005; 44(9): 1090 - 1096. [Full Text] [PDF]
|
|
|
|
|
|
A Swan, H Amer, and P Dieppe The value of synovial fluid assays in the diagnosis of joint disease: a literature survey Ann Rheum Dis, June 1, 2002; 61(6): 493 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Amer, A. Swan, and P. Dieppe The utilization of synovial fluid analysis in the UK Rheumatology, September 1, 2001; 40(9): 1060 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Johnson Diagnosis of Intercritical Gout Ann Intern Med, May 16, 2000; 132(10): 843 - 843. [Full Text] [PDF]
|
|
|
|
 |
|
 Diagnosis of Gout When Patients Are Asymptomatic Journal Watch (General), December 7, 1999; 1999(1207): 5 - 5. [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
